Screening results for non-declared synthetic phosphodiesterase-5 inhibitors being added to dietary supplements of plant origin

Автор: Perova I.B., Eller K.I., Tumolskaya E.V.

Журнал: Анализ риска здоровью @journal-fcrisk

Рубрика: Анализ риска здоровью в гигиене

Статья в выпуске: 3 (27), 2019 года.

Бесплатный доступ

Non-declared addition of synthetic phosphodiesterase-5 inhibitors (PDE-5 inhibitors) to dietary supplements (DS) of plant origin in order to stimulate potency is a serios problem. Such counterfeiting strengthens therapeutic effects produced by a product; similar effects can’t occur only due to components of DS of plant origin. Synthetic PDE-5 inhibitors are both substances of official medications and their structural analogues. When synthetic PDE-5 inhibitors are consumed as components in DS in order to increase potency, it can be hazardous for consumers’ health due to unpredictable or even lethal side effects. Our research goal was to reveal concentrations of non-declared synthetic PDE-5 inhibitors in DS consumed by males. Our research objects were 175 DS selected by Rospotrebnadzor in different Russian regions. Synthetic PDE-5 inhibitors were detected in samples by HPLC with diode array spectrophotometric detection and MS-detection as per guidelines developed by us and approved on by Rospotrebnadzor (MG 4...

Еще

Ds, safety, health risk, synthetic phosphdiesterase-5 inhibitors, tadalafil, vardenafil, sildenafil, hplc-dad-ms

Короткий адрес: https://sciup.org/142223288

IDR: 142223288   |   DOI: 10.21668/health.risk/2019.3.06

Статья научная